Probenecid
ORLYNVAH, a combination of sulopenem etzadroxil, a penem antibacterial, and probenecid, a renal tubular transport inhibitor, is indicated for the treatment of uncomplicated urinary tract infections (uUTI) caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mir…
United States
$23
per month
India
$2
per month
You save
−91%save $21/mo · 91% cheaper
57.8K US scripts/yr$1.2M potential annual savings$1.3M US spend/yr
Drag to rotate · 3D structureC13H19NO4S
SMILES: CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
Compare the price
US price$23per month
India price$2per month
You save$2191% less
Based on 30 units per month. US $0.77 vs India $0.07 per unit.
Total over 1 periodSave $21$23 → $2
The bigger picture
Probenecid is filled about 57.8K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$1.3M
If sourced from India
$123K
Potential annual savings
$1.2M
−91%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.